Effect of entacapone on quality of life in Parkinson's disease.

被引：0
|
作者：
Gordin, A
Reinikainen, K
Durif, F
机构：
[1] Orion Phamaceut Co, Clin Dev, Espoo, Finland
[2] Univ Hosp Clermont Ferrand, Dept Neurol, Clermont Ferrand, France
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2001年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P355
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [1] Effect of entacapone on qualify of life in Parkinson's disease
    Gordin, A
    Reinikainen, K
    Durif, F
    [J]. NEUROLOGY, 2001, 56 (08) : A102 - A102
  • [2] Quality of Life in Early Parkinson's Disease Treated with Levodopa/Carbidopa/Entacapone
    Fung, Victor S. C.
    Herawati, Lilie
    Wan, Ying
    [J]. MOVEMENT DISORDERS, 2009, 24 (01) : 25 - 31
  • [3] Effect of impulse control disorders and related behaviors in quality of life in Parkinson's disease.
    Montero, M. Vales
    Otalora, P. Melgarejo
    Chicote, A. Contreras
    De la Casa Fages, B.
    Sanchez, J. Perez
    Buzo, E. Luque
    Sanchez, M. Gonzalez
    Grandas, F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 719 - 719
  • [4] Entacapone for Parkinson's disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2000, 42 (1070): : 7 - 8
  • [5] Falls in Parkinson's disease. Causes and impact on patients' quality of life
    Michatowska, M
    Fiszer, U
    Krygowska-Wajs, A
    Owczarek, K
    [J]. FUNCTIONAL NEUROLOGY, 2005, 20 (04) : 163 - 168
  • [6] Exercise, supervised or not, effects on life quality of patients with Parkinson's disease.
    Ibarra de Vidal, Lilian del Carmen
    Monzon Rangel, Yolanda
    Araujo, Hilarion
    Jose Salinas, Pedro
    [J]. MEDULA, 2010, 19 (02): : 95 - 101
  • [7] Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson's disease. Pilot study.
    Nevrly, M.
    Ressner, P.
    Nestrasil, I.
    Vranova, H.
    Herzig, R.
    Kanovsky, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 93 - 93
  • [8] Neuropathy in Parkinson's Disease. Comment: Neuropathy in Parkinson's Disease: Risk Determinants and Impact on Quality of Life
    Fustes, Otto J. H.
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (06) : 1213 - +
  • [9] The effect of a structured medication review on quality of life in patients with Parkinson's disease. An interim analysis
    Verbeek, A.
    Oonk, N.
    Munster, E.
    Movig, K.
    ter Huurne, K.
    Nijmeijer, H.
    van der Palen, J.
    Dorresteijn, L.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S170 - S171
  • [10] Entacapone in the treatment of Parkinson's disease
    Schrag, A
    [J]. LANCET NEUROLOGY, 2005, 4 (06): : 366 - 370
12345